| P50 | author | Jean-Martin Beaulieu | Q30513917 |
| P2093 | author name string | Arash Bahremand | |
| | Alesya Evstratova | |
| | Simon Chamberland | |
| | Katalin Toth | |
| | Jivan Khlghatyan | |
| | Aleksandra Marakhovskaia | |
| P2860 | cites work | Genome engineering using the CRISPR-Cas9 system | Q22122027 |
| | A beta-arrestin 2 signaling complex mediates lithium action on behavior | Q24306355 |
| | FXR1, an autosomal homolog of the fragile X mental retardation gene | Q24321996 |
| | Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis | Q24323108 |
| | Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis | Q24529125 |
| | Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 |
| | Multiplex genome engineering using CRISPR/Cas systems | Q24609428 |
| | Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse | Q74060519 |
| | Synapse-specific expression of calcium-permeable AMPA receptors in neocortical layer 5. | Q36579012 |
| | Direct Ventral Hippocampal-Prefrontal Input Is Required for Anxiety-Related Neural Activity and Behavior | Q36599045 |
| | Golgi, Cajal, and the fine structure of the nervous system | Q36672106 |
| | Distribution of CaMKIIα expression in the brain in vivo, studied by CaMKIIα-GFP mice | Q37105888 |
| | Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models | Q37190453 |
| | Akt/GSK3 signaling in the action of psychotropic drugs | Q37301265 |
| | The state of synapses in fragile X syndrome | Q37387721 |
| | Anxiety comorbidity in schizophrenia. | Q38128065 |
| | Anxiety in Patients with Schizophrenia: Epidemiology and Management | Q38611406 |
| | Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders. | Q38691885 |
| | Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice | Q38809906 |
| | Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine | Q38838637 |
| | Genome-wide identification of splicing QTLs in the human brain and their enrichment among schizophrenia-associated loci. | Q38940268 |
| | Analyzing the Role of MicroRNAs in Schizophrenia in the Context of Common Genetic Risk Variants. | Q39931861 |
| | Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels | Q40423316 |
| | PKA-GluA1 coupling via AKAP5 controls AMPA receptor phosphorylation and cell-surface targeting during bidirectional homeostatic plasticity | Q41976523 |
| | Genome wide assessment of mRNA in astrocyte protrusions by direct RNA sequencing reveals mRNA localization for the intermediate filament protein nestin. | Q43951892 |
| | Glutamate Receptor Subunit 2 Serine 880 Phosphorylation Modulates Synaptic Transmission and Mediates Plasticity in CA1 Pyramidal Cells | Q44610940 |
| | Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma | Q46089793 |
| | Conservation of glutamate receptor 2-containing AMPA receptors during long-term potentiation | Q46269497 |
| | The interaction of GSK3B and FXR1 genotypes may influence the mania and depression dimensions in mood disorders | Q47789806 |
| | Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. | Q47860639 |
| | CNO Evil? Considerations for the Use of DREADDs in Behavioral Neuroscience | Q47882302 |
| | Chemogenetics revealed: DREADD occupancy and activation via converted clozapine. | Q47993262 |
| | Targeted in vivo mutations of the AMPA receptor subunit GluR2 and its interacting protein PICK1 eliminate cerebellar long-term depression | Q48615352 |
| | Knockout mouse model for Fxr2: a model for mental retardation | Q48671554 |
| | Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins | Q50303922 |
| | Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits | Q24657867 |
| | Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders | Q26796321 |
| | Phosphorylation of the AMPA receptor subunit GluR2 differentially regulates its interaction with PDZ domain-containing proteins | Q28139757 |
| | Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation | Q28140761 |
| | Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2 | Q28209478 |
| | Light and electron microscopy study of glycogen synthase kinase-3beta in the mouse brain | Q28472669 |
| | Fragile X related protein 1 clusters with ribosomes and messenger RNAs at a subset of dendritic spines in the mouse hippocampus | Q28505448 |
| | PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity | Q28574179 |
| | An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size | Q28587883 |
| | Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting | Q29615874 |
| | Cloned glutamate receptors | Q29619950 |
| | Fragile X Proteins FMRP and FXR2P Control Synaptic GluA1 Expression and Neuronal Maturation via Distinct Mechanisms | Q30279218 |
| | An Expanded View of Complex Traits: From Polygenic to Omnigenic | Q30322686 |
| | The distribution of glutamate receptors in cultured rat hippocampal neurons: Postsynaptic clustering of AMPA selective subunits | Q30464685 |
| | Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour | Q30522548 |
| | Synaptic modifications in the medial prefrontal cortex in susceptibility and resilience to stress | Q33671659 |
| | Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase | Q33886010 |
| | An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. | Q34123789 |
| | The Fragile X mental retardation protein | Q34446600 |
| | Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency | Q34587440 |
| | FXR1P limits long-term memory, long-lasting synaptic potentiation, and de novo GluA2 translation. | Q34625623 |
| | Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex | Q34906869 |
| | Loss of neuronal GSK3β reduces dendritic spine stability and attenuates excitatory synaptic transmission via β-catenin | Q35228923 |
| | A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior. | Q35637848 |
| | Regulation of {alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking through PKA phosphorylation of the Glu receptor 1 subunit | Q35652545 |
| | In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9 | Q35820051 |
| | Glutamate as a therapeutic target in psychiatric disorders | Q35847653 |
| | FXR1P is a GSK3β substrate regulating mood and emotion processing | Q35990042 |
| | FXR1P but not FMRP regulates the levels of mammalian brain-specific microRNA-9 and microRNA-124 | Q36246867 |
| | A genome-wide association study of bipolar disorder with comorbid eating disorder replicates the SOX2-OT region | Q36268966 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 119 | |
| P577 | publication date | 2018-04-12 | |
| P1433 | published in | Frontiers in Molecular Neuroscience | Q27721913 |
| P1476 | title | Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3β Are Modulators of Anxiety and Glutamatergic Neurotransmission. | |
| P478 | volume | 11 | |